Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes (Q34227891)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes |
scientific article |
Statements
1 reference
Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes (English)
1 reference
Julio Rosenstock
1 reference
Naresh Aggarwal
1 reference
David Polidori
1 reference
Yue Zhao
1 reference
Deborah Arbit
1 reference
Keith Usiskin
1 reference
George Capuano
1 reference
William Canovatchel
1 reference
Canagliflozin DIA 2001 Study Group
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference